Payer/Provider Collaboration to Meet Best Practice Standards in Asthma Management

Learn About:

Payer tools to support coordinated care and access to appropriate asthma therapy
Opportunities for primary care to partner with managed care professionals to support coordinated care
The new HEDIS Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E) measure
Team-based treatment strategies
How a multidisciplinary team can reduce diagnostic and treatment delays

Expert Faculty Presenters


	Steven S. Kheloussi, PharmD, MBA, FAMCP (Moderator) Principal Consultant Kheloussi Consulting, LLC Click here for biography

	Njira Lugogo, MD Clinical Professor of Medicine Division of Pulmonary, Critical Care Medicine University of Michigan Director Michigan Medicine Asthma Program Click here for biography

	Njira Lugogo, MD Drake Reiter, PharmD Director, Pharmacy Operations Priority Health Click here for biography

	Karla Stoermer Grossman, MSA, BSN, RN, AE-C Clinical Site Coordinator INHALE Click here for biography

Target Audience
The primary target audience for this initiative consists of asthma care team professionals, including primary care providers, asthma specialists, advanced practitioners (APPs/PAs/NPs), nurses, pharmacists, and other multidisciplinary health care professionals responsible for the treatment management of patients with asthma in community, academic, integrated health systems, health plans and other managed care organizations settings.

Statement of Need/Program Overview
Asthma remains a major public health issue in the US, with many patients still uncontrolled despite available treatments and evidence-based guidelines. This leads to preventable ER visits, hospitalizations, and significant costs—over $80 billion annually. The NCQA has updated HEDIS® for 2026 to include a new measure, Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E), which tracks if patients ages 5–64 receive an outpatient follow-up within 30 days after an asthma-related urgent or emergency visit. . This educational activity is designed to increase awareness of the new HEDIS measure to improve outcomes of patients being treated for asthma for both managed care professionals and primary care providers.

Educational Objectives
After completing this activity, Primary Care Provider participants should be able to demonstrate improved ability to:

Recognize the goals of asthma care, review barriers to appropriate care, and identify opportunities to implement patient-centered decision making
Identify evidence-based asthma therapies that align with current clinical guidelines
Evaluate how a multidisciplinary team can reduce diagnostic and treatment delays and improve delivery of asthma care
Describe opportunities for primary care to partner with managed care professionals to support coordinated care and ensure patient access to appropriate asthma therapy

After completing this activity, Managed Care participants should be able to demonstrate improved ability to:

Review asthma treatment goals, including the new HEDIS Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E) measure, barriers to appropriate care, and opportunities to support patient-centered care
Identify strategies that ensure patient access to evidence-based, guideline-directed asthma therapy
Assess team-based treatment strategies that improve outcomes and reduce care delays after an asthma-related urgent or emergency visit
Examine payer tools to support coordinated care and access to appropriate asthma therapy

Accreditation Information

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Impact Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional Continuing Education (IPCE)
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Physician Continuing Medical Education
Partners designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Partners designates this continuing education activity for 1.0 contact hours (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

UAN: Coming Soon
Type of Activity: Knowledge

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

DISCLOSURE OF CONFLICTS OF INTEREST
Partners for Advancing Clinical Education (Partners) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to Partners policy. Partners is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

*Name of Faculty*	*Reported Financial Relationship*
Steven S. Kheloussi, PharmD, MBA, FAMCP	Nothing to disclose.
Njira Lugogo, MD	Coming soon
Drake Reiter, PharmD	Nothing to disclose.
Karla Stoermer Grossman, MSA, BSN, RN, AE-C	Coming soon

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

FEE INFORMATION
There is no fee for this educational activity.